BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Covington
Johnson and Johnson
Julphar
Healthtrust
Queensland Health
Fuji
Baxter
Citi

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080154

« Back to Dashboard

NDA 080154 describes PROPYLTHIOURACIL, which is a drug marketed by Abbott, Actavis Elizabeth, Anabolic, Ani Pharms Inc, Chartwell Rx, Dava Pharms Inc, Halsey, Hikma Intl Pharms, Impax Labs, Lannett, Lilly, Sun Pharm Industries, Tablicaps, and Watson Labs, and is included in fifteen NDAs. It is available from eight suppliers. Additional details are available on the PROPYLTHIOURACIL profile page.

The generic ingredient in PROPYLTHIOURACIL is propylthiouracil. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the propylthiouracil profile page.
Summary for 080154
Tradename:PROPYLTHIOURACIL
Applicant:Hikma Intl Pharms
Ingredient:propylthiouracil
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 080154
Medical Subject Heading (MeSH) Categories for 080154
Suppliers and Packaging for NDA: 080154
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROPYLTHIOURACIL propylthiouracil TABLET;ORAL 080154 ANDA West-Ward Pharmaceutical Corp 0143-1480 0143-1480-25 100 TABLET in 1 BOX, UNIT-DOSE (0143-1480-25)
PROPYLTHIOURACIL propylthiouracil TABLET;ORAL 080154 ANDA West-Ward Pharmaceutical Corp 0143-1480 0143-1480-01 100 TABLET in 1 BOTTLE (0143-1480-01)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Novartis
Queensland Health
US Department of Justice
Julphar
Cantor Fitzgerald
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot